Cvd Equipment CorpCVV

CVD Equipment Corporation’s latest SEC filing reads like a polite fiction wrapped around a cash-flow problem. The company reports $1.8 million in quarterly revenue, but after all the interest, taxes, and depreciation are settled, the net result is a $1.7 million loss for the three months ended 31 March 2026. Operating income was also in the red at $1.8 million, while operating cash flow came in at minus $852,000. The balance sheet remains solvent-$26.2 million in assets versus $2.9 million in liabilities and $23.3 million equity-but the cash pile is only $8.2 million and the inventory balance fell by $317,000 during the quarter. That’s a company that is still trading while bleeding, not one that is thriving.

What CVD Equipment actually makes are industrial chemical vapour deposition systems: machines that deposit thin films for semiconductors, carbon fibres, and advanced materials. The product rails show a portfolio that spans ALD, APCVD, CVI, HTA, LPCVD, LPE, MOCVD, PECVD, RTP, SAS, UHVCVD, and more. The company’s website displays polished renders of the Carbon+300 and Tow Coat System, but the 10-Q tells a quieter story: the company fulfilled its remaining MesoScribe product orders in 2024, completed the sale of equipment assets, and has since pivoted to selling whatever capital equipment demand still exists in niche industrial niches.

The numbers behind the gloss: for the quarter to 31 March 2026, CVD Equipment recorded revenue of $1.8 million, a net loss of $1.7 million, diluted EPS of minus 24 cents on 6.9 million shares, and negative operating cash flow of $852,000. Capital expenditure was a trifling $13,000, while R&D ran at $727,000. The company’s cash and equivalents stand at $8.2 million, inventory net is $306,000, and total assets are $26.2 million against liabilities of $2.9 million. The Form SD confirms the company still sells MesoScribe products and maintains its equipment portfolio, but the 10-K explicitly states that if ‘funds or demand for capital equipment decline, the demand for our products’ also declines-hardly a ringing endorsement of secular growth.

For a deeper look at price history and liquidity, the source rail provides TradingView context at https://www.tradingview.com/symbols/OTC-CVDD. The company’s business is cyclical capital equipment, so the chart will reflect the same macro impulses that appear in the filings: when industrial customers open their wallets, CVD Equipment’s machines get booked; when purse strings tighten, orders stall. The SEC filings and product pages are the primary evidence; the TradingView chart is secondary context only.

What changed? The quarter’s headline is red ink: revenue flat year-on-year, losses widening, and cash burn accelerating. The evidence shows no new orders of scale, no material capex, and a shrinking inventory base that suggests weak end-market demand rather than lean inventory management. The company’s Form 8-Ks through March and May 2026 confirm routine updates-asset sales, MesoScribe wind-down, and SD disclosures-but none point to a demand inflection. The key question left unanswered is whether the next quarter’s order book will stabilise or continue shrinking. Until orders materially rebound, the company’s $8.2 million cash pile is the only thing standing between it and a rights issue or asset sale.

What remains unproven: the company has not provided segment-level revenue, customer concentration, or order backlog detail in the 10-Q; the SEC filings do not quantify the size or timing of any future contracts; and the product pages do not disclose any firm bookings or firm customer names. The evidence also does not show any material insider buying, buybacks, or equity issuance in the period. The next catalyst would be a quarter with positive operating cash flow, an order backlog disclosure, or a clear statement that demand has troughed. Until then, CVD Equipment remains a niche industrial supplier navigating a soft capital-equipment cycle with a balance sheet that is solvent but increasingly illiquid in practice.